ProfoundBio US Co.

BiotechnologySeries BWoodinville, US

Latest round

Series B

Last raised

Feb 2024

Total raised

$237M

Investors

18

About ProfoundBio US Co.

, operates as a medical company for oncology biotherapeutics firms that are developing innovative antibody-based medicines with the potential to cure cancer patients. In May 2024, Genmab A/S acquired ProfoundBio US Co., Surveyor Capital, and T.8 billion. The company's product pipeline primarily consists of antibody-coupled drugs (ADCs) and other antibody-based therapeutic programs. In addition, it develops novel targeted drugs including PRO1184, an ADC drug targeting folate receptor alpha (FRa), and PRO1160, an ADC drug covering hematologic and solid tumor indications targeting CD70.

Who invested in ProfoundBio US Co.

18 investors across 3 rounds

See all investors in ProfoundBio US Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Feb 13, 2024

    Amount

    $112M

    Investors

    Locked

  2. Series A

    Jun 2, 2022

    Amount

    $70M

    Investors

    Locked

  3. Series A

    Jul 12, 2021

    Amount

    $55M

    Investors

    Locked

Questions about ProfoundBio US Co.

Who invested in ProfoundBio US Co.?

ProfoundBio US Co. has 18 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ProfoundBio US Co. raised?

ProfoundBio US Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did ProfoundBio US Co. last raise money?

ProfoundBio US Co.'s most recent round on record is a Series B, in Feb 2024.

What does ProfoundBio US Co. do?

, operates as a medical company for oncology biotherapeutics firms that are developing innovative antibody-based medicines with the potential to cure cancer patients.

Where is ProfoundBio US Co. headquartered?

ProfoundBio US Co. is headquartered in Woodinville, US.

Which VCs invest in companies like ProfoundBio US Co.?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ProfoundBio US Co.'s stage. Their profiles are linked below.

Raising like ProfoundBio US Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.